Switching to cangrelor in CAD patients pretreated with ticagrelor safe without concerns for drug interactions: SWAP-5 Study Medha Baranwal9 Dec 2022 7:00 AM GMTUSA: The use of cangrelor in stable coronary artery disease (CAD) patients pretreated with ticagrelor results in enhanced platelet inhibition and the...
Nuisance bleeding tied to early increase in bleeding risk in patients with acute MI on DAPT: Circulation Medha Baranwal5 Dec 2022 4:45 AM GMTKorea: A subanalysis of the TALOS-AMI trial has shown nuisance bleeding (NB) to be frequent in patients with acute myocardial infarction (AMI) on...
DAPT with ticagrelor and aspirin combo reduces saphenous vein graft failure in CABG: JAMA Dr.Niharika Harsha B16 Aug 2022 5:30 AM GMTRecent research published in the JAMA Network found that Ticagrelor added to Aspirin was associated with a significantly decreased risk of vein graft...
Sickle cell disease: Ticagrelor fails to reduce vaso-occlusive crises in pediatric cases Dr. Hiral patel10 Aug 2022 4:30 AM GMTUSA: Ticagrelor is not efficient in preventing vaso-occlusive crises in pediatric patients with SCD, shows a phase 3, HESTIA3 study data published in...
Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment period: Neurology Medha Baranwal29 April 2022 7:00 AM GMTChina: A recent study in the journal Neurology found that in patients with mild to moderate ischemic stroke or at high risk for transient ischemic...
Clopidogrel Bests Aspirin for Secondary Prevention of ASCVD MD Bureau1 April 2022 5:15 AM GMTAntiplatelet therapy is the cornerstone for the prevention and treatment of atherothrombosis. Aspirin is the most widely used antiplatelet agent for...
Ticagrelor addition to heparin not tied to improved outcomes in COVID-19: JAMA Medha Baranwal1 March 2022 3:30 AM GMTUSA: The use of a P2Y12 inhibitor in addition to a therapeutic dose of heparin versus heparin alone does not improve survival free of organ support in...
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 12:14 PM GMTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 3:30 AM GMTOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Ticagrelor doesn't improve acute coronary syndrome compared to Prasugrel: Study MD Editorial Team27 Jan 2022 3:00 AM GMTDelhi: A meta-analysis by Fong L.C.W. and team revealed that ticagrelor did not reduce the primary composite endpoint of myocardial infection (MI),...
Efficacy and safety of ticagrelor versus prasugrel not affected by eGFR in ACS patients: ISAR-REACT 5 trial Medha Baranwal12 Jan 2022 3:30 AM GMTGermany: Results from ISAR-REACT 5 trial have shown that a reduction of estimated glomerular filtration rate (eGFR) is related to increased risk for...
Bentracimab effectively reduces antiplatelet effects of ticagrelor: REVERSE-IT Medha Baranwal10 Dec 2021 3:30 AM GMTUSA: Patients undergoing surgery and those with major bleeding when given Bentracimab (PhaseBio), an intravenous reversal agent for ticagrelor,...
